Furthermore, studies have shown that ROCK inhibitors reduce VEGF-induced angiogenesis and tumor cell growth, leading us to hypothesize that HCTZ exerts an anti-angiogenic effect by inhibiting the ROCK pathway. This evidence concerns the gene VEGFA and neoplasm.